Scholarly article on N-(2-methyl-4-((phenylsulfonyl)amino)phenyl)benzenesulfonamide 200348-81-8 from Journal of the American Chemical Society p. 4601,4605

DOI: 10.1021/ja01166a074

Source and publish data:

Journal of the American Chemical Society p. 4601,4605 (1950)

Update date:2022-08-03

Topics:

Authors:

Adams Adams

Nagarkatti

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01166a074

Full text of DOI:10.1021/ja01166a074

Products guided by the article

Product name:N-(2-methyl-4-((phenylsulfonyl)amino)phenyl)benzenesulfonamide

Cas No:200348-81-8

R&D Labs maybe for 200348-81-8

Nowa pharmaceuticals Co., LTD

Contact:86-512-69362780,69362785

Address:No.69 Weixin Road,Weiting Town,Suzhou Industrial Park
Quzhou Aokai Chemical Co., Ltd.

Contact:86-570-3032832

Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Shenzhen HwaGen Pharmaceutical Co., Ltd

website:http://www.rafflespt.com

Contact:+86-752-5538396

Address:Guangdong Huizhou China
Feis International Trade Co,. Ltd

Contact:13961823444-18235944442

Address:Wuxi jiangsu
Lonwin Chemical Group Limited

website:http://www.lonwinchem.com

Contact:Tel: 86-21-59858395

Address:No#966,Huaxu Road,Shanghai 201702,P.R.China

Relevant to this article

A new modification of 1,1′-Bis(diphenylphosphine oxide)ferrocene at 173 K

Doi:10.1107/S0108270197011207
(1997)
Stereoselective inhibition of human butyrylcholinesterase by phosphonothiolate analogs of (+)- and (-)-cocaine

Doi:10.1016/S0006-2952(97)00403-6
(1997)
Synthesis of acetamides via oxidative C–C bond cleavage of ketones catalyzed by Cu-immobilized magnetic nanoparticles

Doi:10.1002/aoc.5855
(2020)
Total synthesis of the novel, immunosuppressive agent (-)-pateamine A from Mycale sp. employing a β-lactam-based macrocyclization

Doi:10.1021/ja973549f
(1998)
Enantioselective synthesis of 4-substituted 2-pyrrolidinones by site- selective C-H insertion of α-methoxycarbonyl-α-diazoacetanilides catalyzed by dirhodium(II) tetrakis[N-phthaloyl-(S)-tert-leucinate]

Doi:10.1016/S0040-4039(97)10493-2
(1998)
In vitrostudies of deferasirox derivatives as potential organelle-targeting traceable anti-cancer therapeutics

Doi:10.1039/d0cc08156f
(2021)

Article Doi

DOI: 10.1021/ja01166a074

Source and publish data: